Status:
COMPLETED
Observational Study on the Management of Patients With Non Small Cell Lung Cancer Adenocarcinoma
Lead Sponsor:
AstraZeneca
Conditions:
Non Small Cell Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The main objective of the study is to determine the proportion of patients with M + mutation status among patients with Non Small Cell Lung Cancer adenocarcinoma.
Detailed Description
MSD
Eligibility Criteria
Inclusion
- Patient with lung cancer (Non Small Cell Lung Cancer adenocarcinoma)
- Patient for whom a search for the mutational status of EGFR (EGFR-M +, M- or Mx) has been done or is being analyzed
Exclusion
- Assessment of mutational status of EGFR is not done
Key Trial Info
Start Date :
September 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2012
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT01167972
Start Date
September 1 2010
End Date
September 1 2012
Last Update
September 10 2012
Active Locations (101)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Abbeville, France
2
Research Site
Aix-en-Provence, France
3
Research Site
Amilly, France
4
Research Site
Angers, France